3b6h

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
Prostacyclin synthase (PGIS) is a cytochrome P450 (P450) enzyme that, catalyzes production of prostacyclin from prostaglandin H(2). PGIS is, unusual in that it catalyzes an isomerization rather than a, monooxygenation, which is typical of P450 enzymes. To understand the, structural basis for prostacyclin biosynthesis in greater detail, we have, determined the crystal structures of ligand-free, inhibitor, (minoxidil)-bound and substrate analog U51605-bound PGIS. These structures, demonstrate a stereo-specific substrate binding and suggest features of, the enzyme that facilitate isomerization. Unlike most microsomal P450s, where large substrate-induced conformational changes take place at the, distal side of the heme, conformational changes in PGIS are observed at, the proximal side and in the heme itself. The conserved and extensive heme, propionate-protein interactions seen in all other P450s, which are largely, absent in the ligand-free PGIS, are recovered upon U51605 binding, accompanied by water exclusion from the active site. In contrast, when, minoxidil binds, the propionate-protein interactions are not recovered and, water molecules are largely retained. These findings suggest that PGIS, represents a divergent evolution of the P450 family, in which a heme, barrier has evolved to ensure strict binding specificity for prostaglandin, H(2), leading to a radical-mediated isomerization with high product, fidelity. The U51605-bound structure also provides a view of the substrate, entrance and product exit channels.
+
Prostacyclin synthase (PGIS) is a cytochrome P450 (P450) enzyme that catalyzes production of prostacyclin from prostaglandin H(2). PGIS is unusual in that it catalyzes an isomerization rather than a monooxygenation, which is typical of P450 enzymes. To understand the structural basis for prostacyclin biosynthesis in greater detail, we have determined the crystal structures of ligand-free, inhibitor (minoxidil)-bound and substrate analog U51605-bound PGIS. These structures demonstrate a stereo-specific substrate binding and suggest features of the enzyme that facilitate isomerization. Unlike most microsomal P450s, where large substrate-induced conformational changes take place at the distal side of the heme, conformational changes in PGIS are observed at the proximal side and in the heme itself. The conserved and extensive heme propionate-protein interactions seen in all other P450s, which are largely absent in the ligand-free PGIS, are recovered upon U51605 binding accompanied by water exclusion from the active site. In contrast, when minoxidil binds, the propionate-protein interactions are not recovered and water molecules are largely retained. These findings suggest that PGIS represents a divergent evolution of the P450 family, in which a heme barrier has evolved to ensure strict binding specificity for prostaglandin H(2), leading to a radical-mediated isomerization with high product fidelity. The U51605-bound structure also provides a view of the substrate entrance and product exit channels.
==About this Structure==
==About this Structure==
Line 14: Line 14:
[[Category: Prostaglandin-I synthase]]
[[Category: Prostaglandin-I synthase]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Chan, N.L.]]
+
[[Category: Chan, N L.]]
-
[[Category: Chiang, C.W.]]
+
[[Category: Chiang, C W.]]
-
[[Category: Hsu, P.Y.]]
+
[[Category: Hsu, P Y.]]
-
[[Category: Li, Y.C.]]
+
[[Category: Li, Y C.]]
-
[[Category: Wang, L.H.]]
+
[[Category: Wang, L H.]]
-
[[Category: Whitby, F.G.]]
+
[[Category: Whitby, F G.]]
-
[[Category: Yeh, H.C.]]
+
[[Category: Yeh, H C.]]
[[Category: BOG]]
[[Category: BOG]]
[[Category: HEM]]
[[Category: HEM]]
Line 40: Line 40:
[[Category: transmembrane]]
[[Category: transmembrane]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Feb 13 08:18:45 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 19:03:41 2008''

Revision as of 17:03, 21 February 2008


3b6h, resolution 1.62Å

Drag the structure with the mouse to rotate

Crystal structure of human prostacyclin synthase in complex with inhibitor minoxidil

Overview

Prostacyclin synthase (PGIS) is a cytochrome P450 (P450) enzyme that catalyzes production of prostacyclin from prostaglandin H(2). PGIS is unusual in that it catalyzes an isomerization rather than a monooxygenation, which is typical of P450 enzymes. To understand the structural basis for prostacyclin biosynthesis in greater detail, we have determined the crystal structures of ligand-free, inhibitor (minoxidil)-bound and substrate analog U51605-bound PGIS. These structures demonstrate a stereo-specific substrate binding and suggest features of the enzyme that facilitate isomerization. Unlike most microsomal P450s, where large substrate-induced conformational changes take place at the distal side of the heme, conformational changes in PGIS are observed at the proximal side and in the heme itself. The conserved and extensive heme propionate-protein interactions seen in all other P450s, which are largely absent in the ligand-free PGIS, are recovered upon U51605 binding accompanied by water exclusion from the active site. In contrast, when minoxidil binds, the propionate-protein interactions are not recovered and water molecules are largely retained. These findings suggest that PGIS represents a divergent evolution of the P450 family, in which a heme barrier has evolved to ensure strict binding specificity for prostaglandin H(2), leading to a radical-mediated isomerization with high product fidelity. The U51605-bound structure also provides a view of the substrate entrance and product exit channels.

About this Structure

3B6H is a Single protein structure of sequence from Homo sapiens with , and as ligands. Active as Prostaglandin-I synthase, with EC number 5.3.99.4 Known structural/functional Sites: , , , , and . Full crystallographic information is available from OCA.

Reference

Structures of Prostacyclin Synthase and Its Complexes with Substrate Analog and Inhibitor Reveal a Ligand-specific Heme Conformation Change., Li YC, Chiang CW, Yeh HC, Hsu PY, Whitby FG, Wang LH, Chan NL, J Biol Chem. 2008 Feb 1;283(5):2917-26. Epub 2007 Nov 21. PMID:18032380

Page seeded by OCA on Thu Feb 21 19:03:41 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools